a National Comprehensive Cancer Network, Fort Washington, Pennsylvania; Smilow Cancer Hospital and Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut; McKesson Specialty Health, The Woodlands, Texas; Research Advocacy Network, Naperville, Illinois; and The University of Texas MD Anderson Cancer Center, Houston, Texas.
Quality measurement in oncology is increasing in significance as payment schemes shift from volume to value. As demand for quality measures increases, challenges in the development of quality measures, standardization across measures, and the limitations of health information technology have become apparent. Moreover, the time and financial burden associated with developing, tracking, and reporting quality measures are substantial. Despite these challenges, best practices and leaders in the field of quality measurement in oncology have emerged. To understand the current challenges and promising practices in quality measurement and to explore future considerations for measure development and measure reporting in oncology, NCCN convened the NCCN Policy Summit: Redefining Quality Measurement in Oncology. The summit included discussion of the current quality landscape and efforts to develop quality measures, use of quality measures in various programs, patient perspective of quality, and challenges and best practices for quality reporting.
Correspondence: Alyssa A. Schatz, MSW, National Comprehensive Cancer Network, 275 Commerce Drive, Suite 300, Fort Washington, PA 19034. Email: firstname.lastname@example.org